Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Leukemia & Lymphoma|March 28, 2024
Olutasidenib in post-venetoclax patients with mutant isocitrate dehydrogenase 1 (m<i>IDH1</i>) acute myeloid leukemia (AML)Jorge Cortes, Brian A Jonas, Gary Schiller, et al.
RSC Chemical Biology|February 27, 2026
Discovery of natural products that modulate signaling in patient-derived cellsJoseph A Balsamo, Hannah L Thirman, Kathryn E Penton, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2025
MDS-associated <i>SF3B1</i> mutations promote aberrant fate choice of hematopoietic stem cell via mis-splicing of mediator kinase module component CDK8Elizabeth A Bonner, Tun-Yun Hsueh, Axia Song, et al.
Nature Chemical Biology|December 3, 2021
Apoptolidin family glycomacrolides target leukemia through inhibition of ATP synthaseBenjamin J Reisman, Hui Guo, Haley E Ramsey, et al.
Leukemia Research|January 9, 2018
Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemiaStephen A Strickland, Aaron C Shaver, Michael Byrne, et al.
Cancer Immunology Research|November 11, 2018
Computational Immune Monitoring Reveals Abnormal Double-Negative T Cells Present across Human Tumor TypesAllison R Greenplate, Daniel D McClanahan, Brian K Oberholtzer, et al.
American Journal of Hematology|May 12, 2020
The use of venetoclax-based salvage therapy for post-hematopoietic cell transplantation relapse of acute myeloid leukemiaMichael Byrne, Nathalie Danielson, Salyka Sengsayadeth, et al.
Blood Cancer Journal|January 15, 2024
Driver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation riskAshwin Kishtagari, M A Wasay Khan, Yajing Li, et al.
Immunohorizons|December 22, 2022
Acly Deficiency Enhances Myelopoiesis through Acetyl Coenzyme A and Metabolic-Epigenetic Cross-TalkDalton L Greenwood, Haley E Ramsey, Phuong T T Nguyen, et al.
Pageof 5